NCT01408615View on ClinicalTrials.gov

A Post Marketing Observational Study of the Safety and Efficacy of Elonva (Corifollitropin Alfa) in General Practice (P08165)

CompletedOBSERVATIONAL
Enrollment

472

Participants

Timeline

Start Date

September 20, 2011

Primary Completion Date

November 18, 2016

Study Completion Date

November 18, 2016

Conditions
Infertility, Female
Interventions
DRUG

corifollitropin alfa

100 or 150 microgram single subcutaneous injection

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT01408615 - A Post Marketing Observational Study of the Safety and Efficacy of Elonva (Corifollitropin Alfa) in General Practice (P08165) | Biotech Hunter | Biotech Hunter